Sensei Biotherapeutics Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: SNSE
Share price (6/3/26): $15.85
Market cap (6/3/26): $21.3 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 141 pages Agreement and Plan of Merger by and Among: Sensei Biotherapeutics, Inc., a Delaware Corporation; Sapphire First Merger Sub, Inc., a Delaware Corporation; Sapphire Second Merger Sub, LLC, a Delaware Limited Liability Company; Faeth Holdings Therapeutics, Inc., a Delaware Corporation; and Faeth Therapeutics, LLC, a Delaware Limited Liability Company Dated as of February 17, 2026

from S-1 53 pages Stock Purchase Agreement by and Among Sensei Biotherapeutics, Inc., and Stockholders of Alvaxa Biosciences, Inc. Dated as of May 18, 2020

from DRS 53 pages Stock Purchase Agreement by and Among Sensei Biotherapeutics, Inc., and Stockholders of Alvaxa Biosciences, Inc. Dated as of May 18, 2020